Striverdi Respimat (Olodaterol)

Olodaterol, a long-acting beta2-adrenergic agonist, is the active ingredient in Striverdi Respimat.

Striverdi Respimat has FDA Boxed Warnings regarding the increased risk of asthma-related death. Before you start using Striverdi Respimat, you should tell your doctor about:, All the medications you take, Your allergies, Your health history and current health problems, Your pregnancy or breastfeeding status, Use your Striverdi Respimat as prescribed by your doctor and do not use more than the recommended dose, as this can cause life threatening heart problems., Striverdi Respimat should not be used to treat acute worsening of COPD., Striverdi Respimat should not be used to treat asthma., Airway constriction can occur immediately after use of Striverdi Respimat. Stop using Striverdi Respimat and seek medical care immediately if this occurs., Caution should be used in patients with seizure disorders, thyroid problems, or sensitivity to drugs that affect the sympathetic nervous system. All the medications you take, Your allergies, Your health history and current health problems, Your pregnancy or breastfeeding status

The most common side effects associated with Striverdi Respimat are a cold, upper respiratory tract infection, bronchitis, urinary tract infection, cough, dizziness, rash, diarrhea, back pain, and joint pain. If you develop side effects that are bothersome or persistent, you should contact their doctor right away.